Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Opinion in Oncology|July 16, 2024
Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensificationFrancesca Poggio, Chiara Molinelli, Irene Giannubilo, et al.The Journal of Vascular Access|November 2, 2019
PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapySergio Bertoglio, Ferdinando Cafiero, Paolo Meszaros, et al.Therapeutic Advances in Medical Oncology|July 12, 2023
Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatmentGuilherme Nader-Marta, Chiara Molinelli, Véronique Debien, et al.Future Oncology (London, England)|August 23, 2023
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancerVéronique Debien, Virginie Adam, Elisabeth Coart, et al.Expert Review of Anticancer Therapy|November 27, 2020
Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacyChiara Molinelli, Francesca Parisi, Maria Grazia Razeti, et al.Breast Care (Basel, Switzerland)|January 2, 2023
HER2-Low Breast Cancer: Where Are We?Chiara Molinelli, Flavia Jacobs, Caterina Marchiò, et al.European Journal of Cancer (Oxford, England : 1990)|October 19, 2023
Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysisDiogo Martins-Branco, Guilherme Nader-Marta, Chiara Molinelli, et al.Cancers|December 8, 2020
Update on the Management of Breast Cancer during PregnancyFrancesca Poggio, Marco Tagliamento, Chiara Pirrone, et al.European Journal of Cancer (Oxford, England : 1990)|December 16, 2023
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysisFlavia Jacobs, Chiara Molinelli, Diogo Martins-Branco, et al.Clinical Medicine Insights. Reproductive Health|August 9, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A ReviewFrancesca Poggio, Matteo Lambertini, Claudia Bighin, et al.Pageof 3